HLA B 27 Disease Association
Also known as: Ankylosing Spondylitis, B27 Disease Association, Disease Association Testing
Use
Evaluate spondyloarthritis and other disorders associated with HLA-B27
Special Instructions
Not provided.
Limitations
Testing requires intact lymphocytes in whole blood specimens. Some samples may not be satisfactory even with precautions, necessitating fresh blood collection. The test does not cover rare HLA alleles that may cause false positives, and additional confirmatory or reflex tests may be needed. Not FDA cleared or approved.
Methodology
PCR-based
Biomarkers
No genes
Gene
LOINC Codes
- 26043-0 - HLA-B27 Ql NAA+probe
- 26043-0 - HLA-B27 Ql NAA+probe
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Adult tube
Minimum Volume
0.5 mL
Container
Lavender-top (EDTA) tube
Storage Instructions
Maintain blood specimen at room temperature.
Causes for Rejection
Hemolysis; clotted specimen; tube other than lavender-top (EDTA) tube
Other tests from different labs that may be relevant